Effects of the DASH Diet and Walking on Blood Pressure in Patients With Type 2 Diabetes and Uncontrolled Hypertension: A Randomized Controlled Trial

Journal of Clinical Hypertension

Volumn 17, Issue 11, 2015, Pages 895-901

  Paula, Tatiana P ^a   Viana, Luciana V ^a   Neto, Alessandra T Z ^a   Leitão, Cristiane B ^a   Gross, Jorge L ^a   Azevedo, Mirela J ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIETARY APPROACHES TO STOP HYPERTENSION; FAT MASS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; OUTPATIENT; PEDOMETER; PHYSICAL ACTIVITY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEDENTARY LIFESTYLE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WALKING; AGED; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIET; FEEDING BEHAVIOR; LIFESTYLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CREATININE; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; FOOD HABITS; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; WALKING;

EID: 84945478755     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12597     Document Type: Article

References (40)

1. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
2. Turner R, Holman R, Stratton I, et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;318:703-713.
3. Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-1576.
4. Viana LV, Leitão CB, Grillo MF, et al. Hypertension management algorithm for type 2 diabetic patients applied in primary care. Diabetol Metab Syndr. 2013;5:52-56.
5. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305:1790-1799.
6. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38(suppl 1):S1-S93.
7. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
8. National Institute for Clinical Excellence (NICE). CG127 hypertension clinical management of primary hypertension in adults. August, 2011.
9. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-2219.
10. Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2013;36:3821-3842.
11. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
12. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
13. Azadbakht L, Nr F, Karimi M, et al. Effects of the dietary approaches to stop hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients. Diabetes Care. 2011;34:55-57.
14. Paula TP, Steemburgo T, Almeida JC, et al. The role of dietary approaches to stop hypertension (DASH) diet food groups in blood pressure in type 2 diabetes. Br J Nutr. 2012;108:155-162.
15. Grossman H. Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care. 2013;36(suppl 2):307-311.
16. Harrington JM, Fitzgerald AP, Kearney PM, et al. DASH diet score and distribuition of blood pressure in midle-aged men and women. Am J Hypertens. 2014;26:1311-1320.
17. Di Loreto C, Fanelli C, Lucidi P, et al. Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care. 2005;28:1295-1302.
18. Colberg SR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33:147-167.
19. Manjoo P, Joseph L, Pilote L, Dasgupta K. Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes. PLoS One. 2010;5:14086-14092.
20. O'Brien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768.
21. WMA Declaration of Helsinki - Ethical principles for medical research involving humans subjects. Adopted by WMA General Assembly, Helsinki Finland.
22. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322:531-536.
23. Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28:164-176.
24. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
25. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
26. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
27. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium restriction on blood pressure in subjects with resistant hypertension. Hypertension. 2009;54:475-481.
28. Leitão CB, Canani LH, Kramer CK, et al. Blood pressure means rather than nocturnal dipping pattern are related to complications in Type 2 diabetic Patients. Diabet Med. 2008;25:308-313.
29. Head GA, McGrath BP, Mihailidou AS, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30:253-266.
30. Johnson ST, Bell GJ, McCargar LJ, et al. Improved cardiovascular health following a progressive walking and dietary intervention for type 2 diabetes. Diabetes Obes Metab. 2009;11:836-843.
31. Figueira FR, Umpierre D, Cureau FV, et al. Association between physical activity advice only or structured exercice training with blood pressure levels in Patients with type 2 diabetes: a systematic review and meta-analysis. Sports Med. 2014;22:1557-1572.
32. Panel on dietary reference intakes for electrolytes and water, standing committee on the scientific evaluation of dietary reference intakes, food and nutrition board. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academies Press; 2004.
33. Mierlo LV, Greyling A, Zock PL, et al. Suboptimal potassium intake and potential impact on population blood pressure. Arch Intern Med. 2010;170:1508-1509.
34. Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:378-396.
35. Mente A, O'Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601-611.
36. Mark DB. B-type natriuretic peptide-biomarker for all seasons? N Engl J Med. 2004;350:718-720.
37. Buckley MG, Markandu ND, Sagnella GA, MacGregor GAJ. Hypertens. Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential Hypertension. J Hypertens. 1994;12:809-813.
38. Khaw KT, Bingham S, Welch A, et al. Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr. 2004;80:1397-1403.
39. Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:1326-1346.
40. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomized trials. BMJ. 2013;346:1325-1340.